# Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

> **NCT00122070** · PHASE3 · COMPLETED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 15 (actual)

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **DRUG:** Quetiapine Fumarate

## Key facts

- **NCT ID:** NCT00122070
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-09
- **Final completion:** 2008-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2008-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122070, "Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00122070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*